Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$10.10
+2.85%
Mkt Cap $760.87M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
Implied Upside
+276.2%
Consensus $38.00 vs current $10.10
NASDAQ·Healthcare·Biotechnology
$10.10
+2.85%
Mkt Cap $760.87M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
+276.2%
Consensus $38.00 vs current $10.10